Verinert for subcutaneous injection 2000, from CSL Behring, contains dried concentrated human C1-inactivator. It is used for the treatment of hereditary angioedema (HAE) by replacing deficient C1-esterase inhibitor, supplied as 2,000 IU per bottle with dissolving solution (YJ code: 6343426D1023).
Verinert for subcutaneous injection 2000
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).